RCUS vs UNP · rev $58.0M vs P/E 21, rev $6.86B
Arcus Biosciences Inc (RCUS) versus Union Pacific Corporation (UNP) — a side-by-side from cached financials, not a winner call.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
Union Pacific Corporation (UNP) is a railroads company listed on NYSE.
Latest reported RCUS revenue for 2026-06-30 was $58.0M. Net income was -$219.0M. RCUS currently screens at market cap $885.2M.
Latest reported UNP revenue for 2026-06-30 was $6.86B. Net income was $1.99B. Revenue was up 10.4% from 2026-03-31 to 2026-06-30. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
RCUS currently screens at market cap $885.2M. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
Not investment advice. Open the RCUS and UNP stock pages for the full models.
Not investment advice.